US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.880
  • -0.070-1.41%
Close May 12 16:00 ET
681.56MMarket Cap-8.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
37.18%2M
-58.19%7.83M
-85.94%1.3M
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
Operating revenue
37.18%2M
-58.19%7.83M
-85.94%1.3M
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
Cost of revenue
17.94%1.79M
-52.88%7.28M
-84.21%1.47M
1.70%2.45M
-3.09%1.85M
-17.61%1.52M
-14.51%15.46M
44.70%9.3M
-70.61%2.41M
19.91%1.91M
Gross profit
440.98%208K
-83.38%542K
-93.33%-174K
-56.14%850K
-108.52%-73K
-110.93%-61K
-75.23%3.26M
-100.81%-90K
77.80%1.94M
209.39%857K
Operating expense
26.39%22.4M
33.75%74.62M
58.51%22.16M
54.18%17.9M
24.60%16.84M
6.20%17.72M
-56.91%55.79M
-59.90%13.98M
-62.15%11.61M
-58.52%13.51M
Selling and administrative expenses
9.84%6.74M
-1.04%21.97M
12.56%5.58M
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
-General and administrative expense
9.84%6.74M
-1.04%21.97M
12.56%5.58M
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
Research and development costs
35.16%15.66M
56.75%52.65M
83.74%16.58M
118.74%13.03M
30.71%11.45M
17.66%11.58M
-65.86%33.59M
-66.13%9.03M
-75.05%5.96M
-65.35%8.76M
Other operating expenses
----
-99.32%-3.82M
-27.94%-1.31M
19.91%-716K
---961K
---833K
---1.91M
---1.02M
---894K
----
Operating profit
-24.79%-22.19M
-41.02%-74.08M
-58.73%-22.33M
-76.29%-17.05M
-33.62%-16.91M
-10.25%-17.78M
54.84%-52.53M
40.68%-14.07M
67.31%-9.67M
60.82%-12.65M
Net non-operating interest income expense
-30.10%1.51M
-3.97%7.64M
-22.30%1.63M
-8.64%1.82M
8.03%2.02M
8.84%2.17M
7.95M
2.1M
-14.03%1.99M
1.87M
Non-operating interest income
-30.10%1.51M
-3.97%7.64M
-22.30%1.63M
-8.64%1.82M
8.03%2.02M
8.84%2.17M
--7.95M
--2.1M
-14.03%1.99M
--1.87M
Other net income (expense)
60.23%854K
101.73%1.52M
101.07%905K
555.32%616K
-169.50%-539K
119.04%533K
-418.54%-87.49M
-400.16%-84.59M
104.72%94K
-107.34%-200K
Special income (charges)
--0
97.43%-2.3M
99.53%-400K
87.50%-100K
-650.00%-1.5M
89.29%-300K
-571.62%-89.41M
-535.18%-85.61M
59.86%-800K
-141.75%-200K
-Less：Restructuring and merger&acquisition
--0
-8.00%2.3M
130.77%400K
-87.50%100K
650.00%1.5M
-89.29%300K
109.29%2.5M
95.06%-1.3M
-52.94%800K
113.33%200K
-Less:Other special charges
----
----
----
----
----
----
1,210.98%86.91M
----
----
----
-Write off
----
----
----
----
----
----
--0
--0
--0
--0
Other non- operating income (expenses)
2.52%854K
99.32%3.82M
27.94%1.31M
-19.91%716K
-48.55%961K
-58.14%833K
-77.51%1.91M
--1.02M
--894K
-16.83%1.87M
Income before tax
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-48.64%-132.07M
-5,096.56%-96.55M
74.07%-7.59M
62.85%-10.99M
Income tax
0
Net income
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
Net income continuous Operations
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
Minority interest income
Net income attributable to the parent company
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
Basic earnings per share
-25.00%-0.15
69.01%-0.53
84.16%-0.16
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
Diluted earnings per share
-25.00%-0.15
69.01%-0.53
84.16%-0.16
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 37.18%2M-58.19%7.83M-85.94%1.3M-24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M
Operating revenue 37.18%2M-58.19%7.83M-85.94%1.3M-24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M
Cost of revenue 17.94%1.79M-52.88%7.28M-84.21%1.47M1.70%2.45M-3.09%1.85M-17.61%1.52M-14.51%15.46M44.70%9.3M-70.61%2.41M19.91%1.91M
Gross profit 440.98%208K-83.38%542K-93.33%-174K-56.14%850K-108.52%-73K-110.93%-61K-75.23%3.26M-100.81%-90K77.80%1.94M209.39%857K
Operating expense 26.39%22.4M33.75%74.62M58.51%22.16M54.18%17.9M24.60%16.84M6.20%17.72M-56.91%55.79M-59.90%13.98M-62.15%11.61M-58.52%13.51M
Selling and administrative expenses 9.84%6.74M-1.04%21.97M12.56%5.58M-13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M
-General and administrative expense 9.84%6.74M-1.04%21.97M12.56%5.58M-13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M
Research and development costs 35.16%15.66M56.75%52.65M83.74%16.58M118.74%13.03M30.71%11.45M17.66%11.58M-65.86%33.59M-66.13%9.03M-75.05%5.96M-65.35%8.76M
Other operating expenses -----99.32%-3.82M-27.94%-1.31M19.91%-716K---961K---833K---1.91M---1.02M---894K----
Operating profit -24.79%-22.19M-41.02%-74.08M-58.73%-22.33M-76.29%-17.05M-33.62%-16.91M-10.25%-17.78M54.84%-52.53M40.68%-14.07M67.31%-9.67M60.82%-12.65M
Net non-operating interest income expense -30.10%1.51M-3.97%7.64M-22.30%1.63M-8.64%1.82M8.03%2.02M8.84%2.17M7.95M2.1M-14.03%1.99M1.87M
Non-operating interest income -30.10%1.51M-3.97%7.64M-22.30%1.63M-8.64%1.82M8.03%2.02M8.84%2.17M--7.95M--2.1M-14.03%1.99M--1.87M
Other net income (expense) 60.23%854K101.73%1.52M101.07%905K555.32%616K-169.50%-539K119.04%533K-418.54%-87.49M-400.16%-84.59M104.72%94K-107.34%-200K
Special income (charges) --097.43%-2.3M99.53%-400K87.50%-100K-650.00%-1.5M89.29%-300K-571.62%-89.41M-535.18%-85.61M59.86%-800K-141.75%-200K
-Less：Restructuring and merger&acquisition --0-8.00%2.3M130.77%400K-87.50%100K650.00%1.5M-89.29%300K109.29%2.5M95.06%-1.3M-52.94%800K113.33%200K
-Less:Other special charges ------------------------1,210.98%86.91M------------
-Write off --------------------------0--0--0--0
Other non- operating income (expenses) 2.52%854K99.32%3.82M27.94%1.31M-19.91%716K-48.55%961K-58.14%833K-77.51%1.91M--1.02M--894K-16.83%1.87M
Income before tax -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-48.64%-132.07M-5,096.56%-96.55M74.07%-7.59M62.85%-10.99M
Income tax 0
Net income -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M
Net income continuous Operations -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M
Minority interest income
Net income attributable to the parent company -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M
Basic earnings per share -25.00%-0.1569.01%-0.5384.16%-0.16-9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.15
Diluted earnings per share -25.00%-0.1569.01%-0.5384.16%-0.16-9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -